AML

Wells Fargo & Co (NYSE:WFC) shares traded lower Thursday after the U.S. Office of the Comptroller of the Currency (OCC) entered into a formal agreement with the company as related to its anti-money laundering (AML) and sanctions risk management practices.  The Details: The OCC said that it...

Cash purchases of residential real estate in the U.S. are on the rise and the Treasury Department on Wednesday proposed new measures aimed at detecting illicit funds flowing through non-financed purchases in the property sector. In a far-reaching paper on money laundering, terrorist financing and...

Binance, the world’s largest cryptocurrency exchange, was fined Tuesday $4.3 billion after CEO Changpeng Zhao pleaded guilty to failing to comply with US anti-money laundering and funding of terrorism laws. At a press conference announcing the record fine, Attorney General Merrick B. Garland...

Binance (CRYPTO: BNB) announced it will be taking firm measures to optimize the company’s security and protect users. What Happened: As per Binance’s recent announcement, users must undertake a three-step verification process to be considered verified Binance customers. The first...

By Gergo Varga Some ecommerce platforms wear their customer due diligence (CDD) practices like a government-mandated albatross around their necks, yet they don’t consider how AML and KYC checks might actually be increasing their margins. Understandably so, really. The ocean of AML and KYC...

Syros Pharmaceuticals Inc (NASDAQ: SYRS) reported initial clinical data over the weekend from an ongoing Phase 2 study of its SY-1425 and SY-1365 therapies for the treatment of genetically defined acute myeloid leukemia, or AML, and myelodysplastic syndrome, or MDS.  The Analyst...

Karyopharm Therapeutics Inc (NASDAQ: KPTI) announced that the interim analysis of its Phase 2 SOPRA study of selinexor monotherapy in acute myelogenous leukemia (AML) failed to meet the primary endpoint of overall survival (OS). Wedbush’s David M. Nierengarten maintaisd an Outperform rating...

Slingshot Insights, a crowdfunded expert network that offers investment research tools, conducted an expert call on Moleculin Biotech Inc (NASDAQ: MBRX) AML drug Annamycin last Friday. The goal of the call was to offer investors the opportunity to better understand how the drug differs from...

Shares of Celator Pharmaceuticals Inc (NASDAQ: CPXX) surged higher by more than 70 percent early Tuesday morning after the company has agreed to be acquired by Jazz Pharmaceuticals plc (NASDAQ: JAZZ) for approximately $1.5 billion, or $30.25 per share. Celator's stock closed for trading at...